baber/WOPTO huggingface dataset:
Patent GB-1342571-A (GB)
Title: Lighting systems for road vehicles
IPC: B60Q11/00
Filed: 1970-06-27
Abstract: 1342571 Vehicle lighting systems JOSEPH LUCAS (INDUSTRIES) Ltd 14 June 1971 [27 June 1970] 31286/70 Heading H2H A lighting system for road vehicles, wherein the system comprises main beam and dipped beam head lamps, is provided with means which ensure that failure of a main beam or a dipped beam headlamp automatically causes the associated dipped beam or main beam lamp to be illuminated. A road vehicle lighting system comprises main beam headlamps 28, 33 and dipped beam headlamps 31, 35 all of which are energizable by a battery 11 when a lighting switch 12 is in position 14. With a dip switch 15 in position 16 the main beam headlamps are energised, the lamp 28 by way of a relay winding 21 and contacts 19a of a relay 19 and the lamp 33 by way of a relay winding 22 and contacts 19d of the relay 19. At the same time a lamp 18 is energized to indicate the energization of the main beam lamps. When the dip switch is in position 17 the relay 19 is energized whereby contacts 19a-19d change over so that the dipped beam lamps 31, 35 are energized. Whenever the main or dipped beam lamps are energized the relays 21, 22 are energized and these relays when energized open contacts 21a, 22a respectively thus opening the interconnecting circuits between main and dipped beam lamps 28, 31 and 33, 35 respectively. Failure of any of the lamps 28, 31, 33, 35 when energized will cause de-energization of either the relay 21 or 22 whereupon its associated contact 21a or 22a will close to complete the associated interconnecting circuit. Thus for example should the dipped beam lamp 31 fail relay 21 will be deenergized contact 21a will close and main beam lamp 28 will be energized at a reduced level by way of resistor 41, the current at this level being insufficient to operate the relay 21. Lamps 36-39 are associated with contacts 19b, 19c of the relay 19 to indicate the energization of the various headlamps. In other embodiments each headlamp is energized by way of a separate relay and one or two indicating lamp(s) only used which lamp(s) may be arranged to indicate failure of any lamp or one of an associated pair. Furthermore duplicate main beam headlamps may be provided which are energized when the normal main beam lamps fail.
Patent GB-1346167-A (GB)
Title: Spectacle wipers
IPC: G02C7/16
Filed: 1971-04-19
Abstract: 1346167 Spectacle wipers M M ANDREW 19 April 1971 [9 Dec 1969] 60005/69 Heading A4F A spectacle wiper comprises an elongate frame with pivoted wiper blades 11, 12, means 21 for retaining the blades in an inoperative position in alignment with the frame and means for moving the blades in an arc to wipe spectacle lenses when attached to a spectacle frame. The frame hooks by slots 5 over a spectacle frame. Helical springs 21 bias the blades to their inoperative position. A lever 22 connected to the blades by wires 25, or ends (16) Fig. 2 (not shown) of the blades themselves, is or are moved to wipe the lenses.
Patent GB-1346613-A (GB)
Title: Air flow mixing device for air conditioning systems
IPC: F24F11/76
Filed: 1971-04-15
Abstract: 1346613 Air conditioning buildings DYNAMICS CORP OF AMERICA 15 April 1971 9484/71 Heading F4V In an air conditioning system, an air mixing device for mounting in a false ceiling plenum chamber, comprises a primary air conduit 32, at least one vane 30 for pre-setting a primary air flow rate, at least one automatically operable vane 38 for maintaining the flow rate constant, a primary air nozzle 20 adjustable in outflow area by at least one vane 48, at least one secondary air induction inlet 28 controlled by a vane 24, and a rod 34 for opening and closing the vanes 30, 48 in unison, the or each vane 24 normally being in the open position and being closable when the vanes 30, 48 are in their fully open positions. In the form shown, air motors 58, 60 for the rod 34 and vanes 24 respectively, are actuated sequentially by a room pneumatic thermostat 62. In another embodiment, the vanes 24 are also controlled by the motor 58 through a modified rod 34. The vanes 38 are spring biased to an open position and actuated by the primary air flow thereover. A Venturishaped section is provided in the conduit downstream of the nozzle 20.
Patent GB-1348622-A (GB)
Title: Methods of manufacturing hot top sleeves
IPC: B22D7/10
Filed: 1972-12-08
Abstract: 1348622 Hot top sleeves and slabs AIKOH CO Ltd 8 Dec 1972 56847/72 Heading B5A [Also in Division C3] A method of making a hot top sleeve or slab comprises mixing the materials with a thermosetting resin binder and an inflammable material (which may be a solvent for the binder), forming green sleeves or slabs from the composition and burning the inflammable material to thermoset the resin and solidify the sleeve or slab. The rosin binder may be a phenol-formaldehyde, urea-formaldehyde, silicone or furan resin. The inflammable material may be benzene, methyl alcohol, ethyl alcohol, ligroin or mineral spirit. The main materials may be porous or non- porous refractories, several examples being given and may contain an oxidizable metal and an oxidizing agent. Alternatively or additionally inorganic or organic fibrous material, carbonaceous material such as coal, coke, charcoal or graphite or fluorides may be used, examples being listed. An example of a suitable composition by weight is aluminium 15%, ferric oxide 10%, potassium nitrate 3%, sodium fluoride 2%, expanded obsidian 40%, silica sand 20%, phenol-formaldehyde resin 10%, the resin being dissolved in methyl alcohol. The expanded obsidian was coated with the resin solution by mixing and then mixed with the other ingredients.
Patent GB-1352764-A (GB)
Title: Support for movable platform
IPC: A61G7/005
Filed: 1971-08-24
Abstract: 1352764 Adjustable hospital beds RUBERY OWEN & CO Ltd 24 Nov 1972 [24 Aug 1971] 39518/71 Heading A4J In a hospital bed having an adjustable mattress support 1 connected to a base 4 by crossing rigid frames 6, 7 pivotally connected at their upper and lower ends to the mattress support and base respectively with one of the upper end connections 13 being slidably connected to the mattress support, the height and inclination of the mattress support can be adjusted by providing two hydraulic jacks 23, 24 between the base and the frames 6, 7 respectively. The two frames are inter-connected adjacent their crossing points by a lost motion connection 13 such that extension of jack 23 raises frame 6 which carries frame 7 with it through the lost motion connection 13 thereby raising the support in a level attitude and extension of jack 24 raises only frame 7 thereby tilting the support. A lost motion linkage 34, 36, 37 is provided between the foot pedals 31, 32 which operate the two jacks 23, 24 respectively, the linkage being such that when pedal 31 is reciprocated jack 23 is directly actuated and jack 24 is actuated through the lostmotion linkage to raise the support in a level attitude and when pedal 32 is reciprocated only jack 24 is actuated to cause tilting of the support. The support may comprise six corrugated, longitudinal members (21), Fig. 2, (not shown), laid side by side with an air gap therebetween for ventilation purposes.
Patent GB-1353957-A (GB)
Title: Platform support device for detachable mounting on a construction  member
IPC: E04G3/00
Filed: 1971-09-17
Abstract: 1353957 Brackets A MYLAEUS [trading as GEBRœDER MYLAEUS] 17 Sept 1971 43457/71 Heading A4B [Also in Divisions E1 and E2] A bracket for supporting a platform or shelf 7 on an upright or horizontal member 5, comprises an elongated support member 3 angularly adjustably secured to a clamp 1, which clamp is bifurcated and has one arm 11 abutting the member 5 and carrying the support member 3 and another arm 12 carrying a screw-bolt 41 which is directed towards the end portion of the arm 11 at an acute angle and is tightenable to clamp the member 5 between the arm 11 and bolt 41. The support member 3 may be of inverted channelsection and, as shown, is pivotally attached at 26 to a vertical bearing plate 2 which also abuts the upright member 5 and which is secured to the clamp 1 by means of a slot in the plate receiving a tongue on the end of the arm 11, with a securing pin 6. The bearing plate 2 and at least one flange of the support member 3 are each formed with an arcuate row of apertures 27, 35 equi-distant from the pivot axis 26, and a pin 8 is inserted through selected aligned apertures to lock the support member 3 in the required orientation. For a horizontal member 5, the clamp 1 and bearing plate 2 are combined as a single vertical plate.
Patent ID-24073-A (ID)
Inventor: ZARKA PHILIPPE ETIENNE
IPC: C08L75/08
Filed: 1998-10-21
Abstract: There is described a polyol formulation comprising 20 to 65 wt.% of polyol of a first type having a number average molecular weight of greater than 800, a hydroxyl value of less than 200 mg KOH/g and an ethylene oxide content of less than 75 wt.% and, forming a miscible mixture therewith, 35 to 80 wt.% of polyol of a second type having a number average molecular weight of less than 1000, a hydroxyl value of greater than 300 mg KOH/g and an amine content (expressed in terms of the percentage of N) of at least 0.2 wt.%. The formulation is especially useful for preparing a semi-flexible polyurethane foam having a softening temperature of 120  DEG C or more which may be used in insulating pipes.
Patent ID-27193-A (ID)
Inventor: FILISAN ANDREA POLO
IPC: H04N7/16
Filed: 1999-01-18
Abstract: The present industrial invention concerns a system for the distribution in a condominium and/or community environment of a plurality of television signals, and/or audio signals, and/or digital audio and/or video signals transmitted with different standards. According to the invention, one or more digital signals can be received by a single user of the system by means of a frequency conversion into a predetermined channel, which can be accessed by said user only. Moreover, the digital signal being present in said channel always has the same modulation and can be selected by said user through control means which send a control signal to selection means.
Patent IL-109873-A (IL)
Title: 5-(2,5-disubstituted phenyl)-1,6-dihydro-7H-pyrazolo (4,3-d)pyrimidin-7-ones for use as medicaments for the treatment of impotence
IPC: A61K31/00
Filed: 1994-06-02
Abstract: The use of a compound of formula (I) wherein R1 is H; C1-C3 alkyl; C1-C3 perfluomalkyl; or C3-C5 cycloalkyl; R2 is H; optionally substituted C1-C6 alkyl; C1-C3 pefluoroalkyl; or C3-C6 cycloalkyl; R3 is optionally substituted C1-C6 alkyl; C1-C6 perfluoroalkyl; C3-C5 cycloalkyl; C3-C6 alkenyl; or C3-C6 alkynyl; R4 is optionally substituted C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkanoyl, (hydroxy)C2-C4 alkyl or (C2-C3 alkoxy)C1-C2 alkyl; CONR5R6; CO2R7; halo; NR5R6; NHSO2NR5R6; NHSO2R8; SO2NR9R10; or phenyl, pyridyl, pyrimidinyl, imidazolyl, oxazolyl, thiazolyl, thienyl or triazolyl any of which is optionally substituted with methyl; R5 and R6 are each independently H or C1-C4 alkyl, or together with the nitrogen atom to which they are attached form an optionally substituted pyrrolidinyl, piperidino, morpholino, 4-N(R11)-piperazinyl or imidazolyl group; R7 is H or C1-C4 alkyl; R8 is optionally substituted C1-C3 alkyl; R9 and R10 together with the nitrogen atom to which they are attached form an optionally su
Patent IL-110148-A (IL)
Title: Heat exchanger
IPC: B21D53/00
Filed: 1994-06-28
Abstract: A heat exchanger comprising: a plurality of parallel heat exchanger tubes (1) with two plane sides (2) and two narrow sides (2a); said heat exchanger tubes having a contour with a width (B) and a height (H) in a direction of flow of a first heat-exchanging medium, wherein said width is much greater than said height; ribs (3) connected to said plane sides of said heat exchanger tubes, said ribs comprised of a rib band (4) folded to a meander-shape with bent portions (5), wherein adjacent ones of said ribs form a channel (3b) of a flow cross-section therebetween for a second heat-exchanging medium; and said ribs having a plurality of openings (9), wherein a size of said opening is at least equal in size to a size of said flow cross- section of said channel between adjacent ones of said ribs.
Patent IL-110489-A (IL)
Title: Ratcheting compression device
IPC: A61B17/58
Filed: 1994-07-28
Abstract: A ratcheting compression device is provided which is very strong, which can be customized in length, which can be retightened periodically to maintain compression, which allows precise placement and alignment of bones with both grossly tuned compression and finely tuned compression, and in which only a limited inventory of parts is required. The two-piece compression device comprises (a) a novel first piece having a bone screw located at a first end thereof and having a ratcheting member located near the second end thereof and comprising teeth having their crests lying substantially in a plane and (b) a novel second piece comprising an anti-rotation member which acts in cooperation with the ratcheting member of the first piece to compress two segments of bone together. In yet other embodiments, two embodiments of a driver are provided for quickly driving the stop onto the ratcheting member to a desired extent. In a further embodiment, a customized method for compressing and fixing a first bone segment and a second bone segment together is provided.
Patent IL-115346-A (IL)
Title: Performance of acid-salt metathetic processes with the aid of cation exchanger membrane
Inventor: EYAL AHARON
IPC: C07C51/02
Filed: 1995-09-19
Abstract: PCT No. PCT/IL96/00105 Sec. 371 Date May 28, 1998 Sec. 102(e) Date May 28, 1998 PCT Filed Sep. 9, 1996 PCT Pub. No. WO97/11047 PCT Pub. Date Mar. 27, 1997A cation exchange membrane mediated acid-salt metathetic process. An aqueous salt solution is placed into a first compartment on one side of the membrane together with an organic amine extractant of limited water miscibility, and an aqueous acid solution is placed into a second compartment on the other side of the membrane. Product acid forms in the first compartment and collects in the organic amine extractant from where it is recovered. The process is particularly suitable for the recovery of a carboxylic acid from its salt.
Patent IL-115826-A (IL)
Title: Pharmaceutical composition comprising erythropoietin for the treatment of rheumatoid arthritis
IPC: A61K38/18
Filed: 1995-10-31
Abstract: A novel use of the known protein erythropoietin (EPO), and/or a derivative, and/or a fragment thereof, is disclosed. EPO is used as a pharmaceutical for the treatment of chronic inflammations. A particularly beneficial result is seen in patients suffering from rheumatoid arthritis (RA). Significant effects are seen in clinical variables such as morning stiffness, swollen joints, and the like.
Patent IL-118638-A (IL)
Title: Beam generator
IPC: H05H1/54
Filed: 1996-06-12
Abstract: A method of generating a high flux density neutral atom or molecule beam which comprises: generating a plasma of electrons and ionized atoms or molecules, applying a voltage across the plasma, accelerating the ions in one direction and drawing an electron flow in the opposite direction, establishing a magnetic field perpendicular to the electric field decreasing electron mobility along the direction of the electric field, positioning a a cathode close to the exit of the beam emitting electrons providing charge neutralization, effecting a charge exchange between accelerated ionized atoms or molecules and neutral atoms or molecules and converting moving ions to moving neutral atoms or molecules, coupling a plasma generating source selected from a helicon source, and ECR source, or a novel source, removing the charged entities from the flow by passing the plasma through an electrostatic or magnetic filter to filter out charge entities, or by effecting charge exchange and recombination, thus providing a neutral atom or molecule beam.
Patent IL-127923-A (IL)
Title: Oral contraceptive
IPC: A61K31/57
Filed: 1997-07-23
Abstract: This invention provides a method of contraception which comprises administering to a female of child bearing age for 23-25 consecutive days, a first phase combination of a progestin at a daily dosage of 40-500  mu g trimegestone, 250  mu g - 4mg dienogest, or 250  mu g - 4mg drospirenone, and an estrogen at a daily dosage equivalent in estrogenic activity to 10-20  mu g ethinyl estradiol for 3-8 days beginning on day 1 of the menstrual cycle, wherein the same dosage of the progestin and estrogen combination is administered in each of the 3-8 days, a second phase combination of a progestin at a daily dosage of 40-500  mu g trimegestone, 250  mu g - 4 mg dienogest, or 250  mu g - 4 mg drospirenone, and an estrogen at a daily dosage equivalent in estrogenic activity to 10-20  mu g ethinyl estradiol, for 4-15 days, beginning on the day immediately following the last day of administration of the first phase combination, wherein the same dosage of the progestin and estrogen combination is administered in each of the 4-15 days, and a third phase combination of a progestin at a daily dosage of 40-500  mu g trimegestone, 250  mu g - 4 mg dienogest, or 250  mu g - 4 mg drospirenone, and an estrogen at a daily dosage equivalent in estrogenic activity to 10-20  mu g ethinyl estradiol, for 4-15 days beginning on the day immediately following the last day of administration of the second phase combination, wherein the same dosage of the progestin and estrogen combination is administered in each of the 4-15 days provided that the daily dosage of the combination administered in the first phase is not the same as the daily dosage of the combination administered in the second phase and that the daily dosage of the combination administered in the second phase is not the same as the daily dosage of the combination administered in the third phase.
Patent IL-130954-A (IL)
Title: HUMAN NEURTURIN RECEPTOR- a (NTNR a ) POLYPEPTIDES, ANTIBODIES TO NTNR a AND COMPOSITION COMPRISING THE SAME
IPC: A61K39/395
Filed: 1999-07-15
Abstract: NTNR alpha , NTNR alpha  extracellular domain (ECD), NTNR alpha variants, chimeric NTNR alpha  (e.g., NTNR alpha  immunoadhesion), and antibodies which bind thereto (including agonist and neutralizing antibodies) are disclosed. Various uses for these molecules are described, including methods to modulate cell activity and survival by response to NTNR alpha -ligands, for example NTN, by providing NTNR alpha  to the cell.
Patent IL-133814-A (IL)
Title: Process for the preparation of 1-aryl-3-cyclopropyl-1,3-propanediones
IPC: C07C323/22
Filed: 1998-07-03
Abstract: A process for preparing a compound of the formula:which comprises reacting a compound of the formula:wherein R1 is C1-6 straight- or branched-chain alkyl, with a compound of the formula:in an aprotic solvent in the presence of base.
Patent IL-153560-A (IL)
Title: (-)-5-(3-CHLOROPHENYL )-ALPHA-(4-CHLOROPHENYL)-ALPHA-(1-METHYL-1H-IMIDAZOL-5-YL)-TETRAZOLO[1,5-a] QUINAZOLINE-7-METHAMINE AS ANTI-ARTHROPATHY AND ANTI-INFLAMMATORY MEDICAMENT
IPC: A61K31/519
Filed: 2002-12-19
Abstract: (-)-5-(3-Chlorophenyl)-alpha-(4-chlorophenyl)-alpha-(1-methyl-1H-imidazol-5-yl)tetrazolo-[1,5-a]quinazoline-7-methanamine and its pharmaceutically acceptable acid addition salts, and the use of such compounds in medicine especially for the treatment of cancer
Patent IL-155804-A (IL)
Title: Identity-based distributed computing for device resources
IPC: G06F13/38
Filed: 2003-05-08
Abstract: A system, method and related data structures for discovering and describing computing resources available at various computing devices, and for exposing those resources as services that are addressable by software applications. The data describing the resources is arranged according to an identity-based schema. The computing resources may include, for example, storage capacity, bandwidth, processing power, input methods and mechanism, and rendering methods. The method and system are identity-based, whereby a user (with an identity) has access to the distributed resources commensurate with that identity. <IMAGE>A system, method and related data structures for discovering and describing computing resources available at various computing devices, and for exposing those resources as services that are addressable by software applications. The data describing the resources is arranged according to an identity-based schema. The computing resources may include, for example, storage capacity, bandwidth, processing power, input methods and mechanism, and rendering methods. The method and system are identity-based, whereby a user (with an identity) has access to the distributed resources commensurate with that identity. <IMAGE>
Patent IL-163884-A (IL)
Title: Preparation of medicaments to promote neuronal plasticity
IPC: A61P25/28
Filed: 2004-09-02
Abstract: The invention provides a method of promoting neuronal plasticity in the CNS of a mammal, the method comprising administering to the CNS of the mammal an agent that reduces the inhibitory properties of chondroitin sulphate proteoglycans. Preferred agents are chondroitinases and sulfatases, e.g. chondroitinase ABC. Also provided are methods of identifying further agents.
Patent IL-163918-A (IL)
Title: Control moment gyro for attitude control of spacecraft
IPC: G01C19/02
Filed: 2004-09-06
Abstract: The wheel (14) rotates about an horizontal axis and is mounted on a support structure (12). The support structure has an upper web (20) which bears the wheel on one side and is integral with an inverted conical section and tubular sections of decreasing diameter (22,24,26). Angled roller bearings (18) allow electric motors (30) to rotate the support structure about the base (10)
Patent IL-176617-A (IL)
Title: Waterproof vapor-permeable multilayer article
IPC: B32B7/02
Filed: 2006-06-29
Abstract: A waterproof vapor-permeable multilayer article, comprising at least one first layer made of a material that is vapor-permeable and microporous and is at least partially hygroscopic or can assume hygroscopic characteristics over time, and at least one second layer that is waterproof and vapor-permeable.
Patent IL-181025-A (IL)
Title: Anti-igf-ir antibodies, uses thereof and compositions comprising same
IPC: A61K/
Filed: 2007-01-29
Abstract: An isolated antibody or one of its functional fragments able to bond with human Insulin-like Growth Factor-I Receptor (IGF-IR) and, if necessary, inhibit the natural fixing of IGF1 and/or IGF2 ligands and/or capable of specifically inhibiting the tyrosine kinase activity of the IGF-IR receptor, is new. A new isolated antibody or one of its functional fragments is able to bond with human Insulin-like Growth Factor-I Receptor (IGF-IR) and, if necessary, inhibit the natural fixing of IGF1 and/or IGF2 ligands and/or is capable of specifically inhibiting the tyrosine kinase activity of the IGF-IR receptor. It comprises a light chain with at least one CDR (complementarity-determining region) determining the complementarity selected from the CDRs of SEQ ID No: 1, 2, 3 sequences or at least one CDR with its sequence being at least 80 per cent identical after optimal alignment with the SEQ ID No: 1, 2 or 3 sequences, and/or a heavy chain with at least one CDR selected from the CDRs of sequences SEQ ID No: 4, 5 and 6, or at least one CDR having at least 80 per cent identity after optimal alignment with the SEQ ID No: 4, 5 and 6 sequences. The antibody, called 13F5, comprises a heavy chain with the amino-acid sequence SEQ ID No: 20 and a light chain containing the amino acid sequence SEQ ID No: 19. All the sequences are given in the specification. - ACTIVITY : Cytostatic. - MECHANISM OF ACTION : IGF-IR antagonist.